{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:45:14Z","timestamp":1794012314681,"version":"4.8.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001717","name":"Universiteit Leiden","doi-asserted-by":"publisher","award":["LuVDS24.021"],"award-info":[{"award-number":["LuVDS24.021"]}],"id":[{"id":"10.13039\/501100001717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202006210040"],"award-info":[{"award-number":["202006210040"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["B19.008"],"award-info":[{"award-number":["B19.008"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ard.2025.06.2130","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T03:48:32Z","timestamp":1752896912000},"page":"1641-1648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Development of bispecific antibodies that drive selective targeted local complement inhibition on rheumatoid arthritis-related antigens"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1764-4385","authenticated-orcid":false,"given":"Haiyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3709-1526","authenticated-orcid":false,"given":"Saskia","family":"Nugteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3227-8260","authenticated-orcid":false,"given":"Rick J.","family":"Groenland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6496-603X","authenticated-orcid":false,"given":"Stef","family":"van der Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7119-2179","authenticated-orcid":false,"given":"Hanneke","family":"Kapsenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4033-4024","authenticated-orcid":false,"given":"Christoph","family":"Gst\u00f6ttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6394-0783","authenticated-orcid":false,"given":"Elena","family":"Dom\u00ednguez-Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6760-4648","authenticated-orcid":false,"given":"Jan Piet","family":"van Hamburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8940-1788","authenticated-orcid":false,"given":"Sander W.","family":"Tas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9618-6414","authenticated-orcid":false,"given":"Rene E.M.","family":"Toes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4365-3859","authenticated-orcid":false,"given":"Paul W.H.I.","family":"Parren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5186-2290","authenticated-orcid":false,"given":"Leendert A.","family":"Trouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2025.06.2130_bib0001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Res"},{"issue":"23","key":"10.1016\/j.ard.2025.06.2130_bib0002","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ard.2025.06.2130_bib0003","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00002281-200405000-00013","article-title":"Rheumatoid factor revisited","volume":"16","author":"D\u00f6rner","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ard.2025.06.2130_bib0004","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.immunol.26.021607.090244","article-title":"Immunity to citrullinated proteins in rheumatoid arthritis","volume":"26","author":"Klareskog","year":"2008","journal-title":"Annu Rev Immunol"},{"issue":"42","key":"10.1016\/j.ard.2025.06.2130_bib0005","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.ard.2025.06.2130_bib0006","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.ard.2025.06.2130_bib0007","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3899\/jrheum.140767","article-title":"Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis","volume":"42","author":"Gan","year":"2015","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.ard.2025.06.2130_bib0008","first-page":"284","article-title":"Fc gamma receptor binding profile of anti-citrullinated protein antibodies in immune complexes suggests a role for Fc\u03b3RI in the pathogenesis of synovial inflammation","volume":"36","author":"Kempers","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.ard.2025.06.2130_bib0009","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/art.24622","article-title":"Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways","volume":"60","author":"Trouw","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"14","key":"10.1016\/j.ard.2025.06.2130_bib0010","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.molimm.2011.04.024","article-title":"Complement activation by (auto-) antibodies","volume":"48","author":"Daha","year":"2011","journal-title":"Mol Immunol"},{"issue":"4","key":"10.1016\/j.ard.2025.06.2130_bib0011","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/ard.2006.064782","volume":"66","author":"Mullazehi","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.ard.2025.06.2130_bib0012","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/art.1780341209","article-title":"Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis","volume":"34","author":"Brodeur","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ard.2025.06.2130_bib0013","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/art.1780200202","article-title":"Correlation between levels of breakdown products of C3, C4, and properdin factor B in synovial fluids from patients with rheumatoid arthritis","volume":"20","author":"Perrin","year":"1977","journal-title":"Arthritis Rheum"},{"issue":"27","key":"10.1016\/j.ard.2025.06.2130_bib0014","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm6627e1","article-title":"High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine","volume":"66","author":"McNamara","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ard.2025.06.2130_bib0015","article-title":"Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ard.2025.06.2130_bib0016","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/annrheumdis-2019-216499","article-title":"Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications","volume":"79","author":"Kissel","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"10.1016\/j.ard.2025.06.2130_bib0017","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1073\/pnas.1220145110","article-title":"Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange","volume":"110","author":"Labrijn","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ard.2025.06.2130_bib0018","doi-asserted-by":"crossref","first-page":"570","DOI":"10.55563\/clinexprheumatol\/0ms5pk","article-title":"Mass-spectrometric identification of carbamylated proteins present in the joints of rheumatoid arthritis patients and controls","volume":"39","author":"Verheul","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.ard.2025.06.2130_bib0019","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrrheum.2017.15","article-title":"Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis","volume":"13","author":"Trouw","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"10.1016\/j.ard.2025.06.2130_bib0020","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.4049\/jimmunol.1402334","article-title":"IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor- and complement-dependent effector functions of the disease-specific anti-citrullinated protein autoantibodies","volume":"194","author":"Anquetil","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.ard.2025.06.2130_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101339","article-title":"Complement activation and regulation in rheumatic disease","volume":"45","author":"Dijkstra","year":"2019","journal-title":"Semin Immunol"},{"issue":"11","key":"10.1016\/j.ard.2025.06.2130_bib0022","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt1344","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10.1016\/j.ard.2025.06.2130_bib0023","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4049\/jimmunol.1800998","article-title":"C1s inhibition by BIVV009 (Sutimlimab) prevents complement-enhanced activation of autoimmune human B cells in vitro","volume":"202","author":"Nikitin","year":"2019","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.ard.2025.06.2130_bib0024","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ymthe.2024.02.001","article-title":"C3d-targeted factor H inhibits tissue complement in disease models and reduces glomerular injury without affecting circulating complement","volume":"32","author":"Liu","year":"2024","journal-title":"Mol Ther"},{"key":"10.1016\/j.ard.2025.06.2130_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.929483","article-title":"Streptococcus pneumoniae interactions with the complement system","volume":"12","author":"Gil","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ard.2025.06.2130_bib0026","first-page":"vkaf053","article-title":"Tissue-targeted regulators of complement for amelioration of human disease: rationale and novel therapeutic strategies","author":"Liu","year":"2025","journal-title":"J Immunol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725041834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725041834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:19:12Z","timestamp":1777382352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725041834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0003496725041834"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.06.2130","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of bispecific antibodies that drive selective targeted local complement inhibition on rheumatoid arthritis-related antigens","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.06.2130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}